Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	35.63	66.89	130.1	122.16	43.78
Short-Term Investments	135.93	176.64	47.5	72.08	-
Cash & Short-Term Investments	171.56	243.52	177.61	194.24	43.78
Cash Growth	-29.55%	37.11%	-8.56%	343.70%	568.15%
Accounts Receivable	-	-	-	-	0.11
Other Receivables	0.63	0.4	0.11	0.1	-
Receivables	0.63	0.4	0.11	0.1	0.11
Inventory	0.16	0.1	0.2	0.08	0.09
Prepaid Expenses	0.86	0.81	1.11	1.51	0.01
Other Current Assets	5.1	1.79	1.31	2.73	0.45
Total Current Assets	178.31	246.62	180.33	198.66	44.43
Property, Plant & Equipment	0.34	0.5	0.27	0.04	-
Long-Term Investments	59.97	62.55	15.84	31.62	-
Other Long-Term Assets	0.38	0.45	0.15	0.01	-
Total Assets	238.99	310.13	196.59	230.33	44.43
Accounts Payable	5.65	1.38	1.64	1.09	0.53
Accrued Expenses	21.6	10.51	5.94	3.86	0.33
Current Portion of Leases	0.13	0.87	0.11	-	-
Other Current Liabilities	0.23	0.21	0.13	0.2	5.5
Total Current Liabilities	27.61	12.97	7.81	5.15	6.37
Long-Term Debt	29.42	29.9	-	-	-
Long-Term Leases	0.15	0.28	-	-	-
Total Liabilities	57.18	43.15	7.81	5.15	6.37
Common Stock	0.01	0.01	0	0	-
Additional Paid-In Capital	506.99	489.45	359.95	352.98	8.37
Retained Earnings	-325.13	-222.8	-170.43	-127.57	-26.97
Comprehensive Income & Other	-0.05	0.31	-0.75	-0.23	-
Total Common Equity	181.82	266.97	188.78	225.18	-18.59
Shareholders' Equity	181.82	266.97	188.78	225.18	38.06
Total Liabilities & Equity	238.99	310.13	196.59	230.33	44.43
Total Debt	29.7	31.05	0.11	-	-
Net Cash (Debt)	201.82	275.03	193.34	225.86	43.78
Net Cash Growth	-26.62%	42.25%	-14.40%	415.92%	568.15%
Net Cash Per Share	3.36	5.66	4.76	11.26	104.45
Filing Date Shares Outstanding	60.57	60.08	41.03	40.47	0.42
Total Common Shares Outstanding	60.09	57.91	41.03	40.47	0.42
Working Capital	150.7	233.64	172.52	193.51	38.06
Book Value Per Share	3.03	4.61	4.60	5.56	-44.35
Tangible Book Value	181.82	266.97	188.78	225.18	-18.59
Tangible Book Value Per Share	3.03	4.61	4.60	5.56	-44.35

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q